PRNewsWire
05 Jun 2026, 07:45 UTC · 2h ago
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
PRNewsWire
05 Jun 2026, 07:45 UTC · 2h ago
Story key points
2 claims · impact-rated
The lawsuit claims Immutep knew the TACTI-004 trial would fail to meet primary efficacy endpoints despite publicly reporting 'strong operational progress'. — Claims that a company knowingly misrepresented the efficacy of a primary drug candidate strike at the core valuation of a biotech company.
-0.70Immutep Limited is facing a class action lawsuit alleging it made false and misleading statements regarding the progress of its TACTI-004 trial of eftilagimod alfa. — Securities litigation alleging clinical trial failure and corporate deception typically triggers significant negative investor sentiment and stock price volatility.
-0.60Ticker attribution
Model heads
The company is being sued for securities law violations.
Continue reading
6 related stories
Top 3 movers · tap to explore
The company is being sued for securities law violations.
The company is facing a class action lawsuit alleging false and misleading statements regarding clinical trial progress.
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
2 dimensions · 9 clusters
Market reaction
0 bid · 10 offered
No stock impact ranking available yet.
PRNewsWire
3h ago
